制度・支援
指定難病 — No.182

アペール症候群

検索語 Apert Syndrome ・ 最終更新 2026-07-22 21:27 ・ 最新に更新

Data Sheet
指定 No.182
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

不明
MK-01 · PMID 42383896

Patient-Specific 3D Printed Palatal Protection Plates for Le Fort III Osteotomy in Syndromic Midface Hypoplasia: What We Do

Abstract / 原文

BackgroundSyndromic midface hypoplasia often includes a high or fragile palate that is vulnerable during midfacial disimpaction.SolutionWe created a patient-specific palatal protection plate produced through a fully digital workflow to stabilize and protect the palate.What we didAfter using conventional plates from 2022 to 2024, we implemented a digital design and printing workflow in 2025 and added suction-catheter sleeves to the Rowe forceps branches to improve retention.

Journal
The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association(2026 Jul)
Authors
7名
Type
Journal Article
PubMedで原文を見る
不明
MK-02 · PMID 42340830

Discussion: The APERT Severity Scale: A Quantitative Tool for Risk Stratification in Apert Syndrome

Journal
Plastic and reconstructive surgery(2026 Jul)
Authors
1名
Type
Journal Article
PubMedで原文を見る
観察研究
MK-03 · PMID 42331620

Hypoplastic vestibular aqueduct in congenital temporal bone anomalies - implications for subtype diagnosis of Meniere's disease

Abstract / 原文

BACKGROUND AND PURPOSE: As the endolymphatic (ES) undergoes normal postnatal maturation, the surrounding vestibular aqueduct (VA) undergoes a corresponding change in morphology, quantified by its angular trajectory (ATVA). In adult temporal bones with Meniere's disease (MD), a fetal orientation ATVA (≥140°) indicates underlying ES hypoplasia and defines the so called hypoplastic disease endotype (MD-hp). However, ES hypoplasia has also been described histologically in other inner ear syndromes and congenital conditions, independent of MD. We aimed to investigate whether ATVA ≥140° occurs in mature temporal bones beyond its established association with the MD-hp endotype. MATERIALS AND METHODS: Retrospective retrieval of CT scans performed on patients over age 12 years at Massachusetts Eye and Ear between January 2016 and December 2024 was conducted, with search terms encompassing diseases previously described to be associated with temporal bone anomalies. CT studies that did not allow adequate assessment of the VA were excluded. Two neuroradiologists blinded to clinical information independently performed ATVA measurements, with consensus interpretation rendered for disagreements in ATVA categories (adult, intermediate, or fetal orientation). RESULTS: 103 patients with congenital temporal bone anomalies were identified. 98 patients (190 ears) met inclusion criteria. Fetal VA orientation (ATVA ≥140°) was identified in 8 ears from 6 patients. Intermediate VA orientation (ATVA 121°-139°) was identified in 19 ears from 15 patients. Among 8 patients with branchio-oto-renal (BOR) syndrome, 2 patients had bilateral fetal orientation ATVA and 2 patients had mixed fetal/intermediate orientation ATVA. Among 11 patients with trisomy 21, 5 demonstrated unilateral abnormal ATVA. Higher than 120° ATVA values were also observed in CHARGE syndrome, Apert syndrome, and Chiari I malformation. Review of clinical records did not show a diagnosis of MD within our cohort. CONCLUSIONS: Fetal and intermediate ATVA orientations were observed in several congenital temporal bone anomalies without documented MD. These findings further support that abnormal ATVA reflects altered VA/ES developmental morphology and is not exclusive to the MD-hp endotype. Accordingly, fetal orientation ATVA should be interpreted within the broader clinical and radiologic context, particularly in the presence of additional congenital abnormalities.

Journal
AJNR. American journal of neuroradiology(2026 Jun)
Authors
7名
Type
Journal Article
PubMedで原文を見る
症例報告
MK-04 · PMID 42299403

Prenatal diagnosis of apert syndrome at 23 weeks: a case report with isolated syndactyly and sacrococcygeal appendage preceding cranial malformation

Abstract / 原文

BACKGROUND: Apert syndrome is a rare congenital malformation caused by a mutation in the fibroblast growth factor receptor 2 (FGFR2) gene. Characteristic imaging findings include bilateral premature closure of the coronal suture, midfacial hypoplasia, and symmetrical syndactyly of the fingers and toes. These features may be accompanied by lateral ventricle dilation, absence of the corpus callosum, cervical vertebral fusion, and other anomalies. However, in the second trimester, syndactyly and extracranial anomalies may be the only detectable signs, which complicate early diagnosis. The purpose of this study is to improve the early diagnosis rate of Apert syndrome. CASE DESCRIPTION: We report an atypical case of Apert syndrome carrying the FGFR2 S252W mutation, which typically associated with severe cranial deformities and cleft palate, but prenatal ultrasound at 23 weeks revealed symmetrical syndactyly of both hands and feet and a sacrococcygeal soft tissue mass resembling a "tail" without cranial abnormalities. Although prior studies have linked this mutation to advanced paternal age, the father in this case was 25 years old, which does not align with this association. CONCLUSIONS: This case demonstrated that Apert syndrome may present prenatally features other than cranial abnormalities. A practical screening strategy should therefore combine detailed second-trimester ultrasound evaluation of extremities and cardiac structures with prenatal genetic testing, even in the absence of cranial abnormalities.

Journal
AME case reports(2026)
Authors
4名
Type
Case Reports, Journal Article
PubMedで原文を見る
観察研究
MK-05 · PMID 42224039

A 3-Dimensional Morphable Model of the Apert Mandible

Abstract / 原文

BACKGROUND: Patients with Apert syndrome frequently experience breathing problems alongside characteristic malformations. The relatively under-investigated Apert mandible position, development, and morphology may be implicated. Three-dimensional morphable models (3DMMs) can represent, quantitatively analyze, and identify parameters for shape of similar, 3-dimensional, biological objects. This study aims to develop an Apert mandible 3DMM, investigate effects of age, sex, and genetic mutation on Apert mandibular shape, characterize Apert mandibular growth by age. METHODS: High-quality Apert head computerized tomography (CT) scans without previous mandibular surgery, taken 1987 to 2020 were sourced from 2 European pediatric specialist hospitals. Two Apert mandible 3DMMs were constructed from the scans using a standardized pipeline: a size and shape version, and a shape-only version. Subgroup analyses included ages 0 to 4 and 11 to 17 years. RESULTS: Two hundred thirty-eight Apert CT scans, from 103 patients aged 0.1 to 23.2 years, were used to develop 2 Apert mandible 3DMMs. All groups in both models showed no patterns for sex or genetic mutation (Ser252Trp or Pro253Arg) in t-Distributed Stochastic Neighbour embedding and true age was significantly positively correlated with model-predicted age (r=0.45-0.94, P<0.05). First principal component visualization of the Apert mandible 3DMMs suggested macroscopic shape differences compared with the healthy mandible. CONCLUSIONS: Apert mandible 3DMMs were successfully constructed and characterized for growth by age. The Apert mandible 3DMMs suggested macroscopic shape differences but no variation in shape according to sex or genetic mutation. Further research will quantify Apert and healthy mandible shape differences. Apert 3DMMs have potential for used in automated diagnosis of Apert syndrome and personalized surgical planning.

Journal
The Journal of craniofacial surgery(2026 Jun)
Authors
9名
Type
Journal Article
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 2件

日本で参加できる治験

現在 募集中のもの

各治験の「対象の目安」は年齢などの参加条件の一部です。ここに合っていても他の条件(病状・治療歴など)があります。詳しい参加条件は各治験ページで確認し、参加の可否は必ず主治医とご相談ください。

募集中
TR-01 · NCT07710885

Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer

Phase
PHASE3
対象の目安
18歳以上
Country
日本・オーストラリア・タイ・韓国
詳細・参加条件を見る
募集中
TR-02 · NCT04962867

NCCH2006/MK010 Trial (FORTUNE Trial)

Phase
PHASE2
対象の目安
20歳以上
Country
日本
詳細・参加条件を見る
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件をご確認ください。

※ jRCTは自動の大量データ取得を禁じているため、本サービスはjRCTを自動収集せず、患者ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度アペール症候群の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。